Wide variations in appropriateness of rectal cancer surgery across England

The variation was not associated with how far the disease had advanced or how old the patient was, the data showed.

The findings are based on information obtained from the eight cancer registries in England, which track the progress of all patients with cancer, and NHS hospital data on admissions and treatment between1998?.

During this period, 58 290 patients were diagnosed with rectal cancer in England, of whom 31 223 underwent major abdominal surgery in 153 hospitals to treat their disease.

Around 13 000 people are diagnosed with rectal cancer every year in the UK, and the disease has an annual death toll of around 5000.

There are several different surgical approaches to rectal cancer treatment, the most common of which used to be abdominoperineal excision, or APE for short.

This involves the removal of the anal sphincter, necessitating the permanent use of a colostomy bag. But mounting evidence indicates that although APE is unavoidable in some patients, it should not be the preferred procedure for most of them.

Furthermore, the evidence shows that APE is also associated with higher rates of recurrence and poorer survival than a procedure called anterior resection, or AR for short.

The Department of Health has published guidance, encouraging surgeons, wherever possible, to use alternative methods and adopt AR, which obviates the need for a colostomy bag.

The figures showed that many surgeons had taken the evidence on board, because rates of APE fell from almost one in three procedures (30.5%) in 1998 to almost one in four (23%) in 2004.

But there were wide variations in the use of APE among different cancer networks, individual surgeons as well as hospital trusts, where rates varied from 8.5% to almost 53%.

In 1998, one in three patients were also operated on a by a surgeon who performed fewer than seven rectal cancer procedures in a year. By 2004, this had fallen to around one in four (26.5%).

Patients treated by a specialist surgeon undertaking seven or more cases of rectal cancer a year were 23% less likely to be treated with APE than those with less experience.

The figures also revealed that those living in the most deprived areas of the country were significantly more likely to receive an APE than those living in the most affluent areas.

There were no obvious clinical reasons for these discrepancies, the findings showed.

APE may not only spell poorer quality of life for patients, but it is also more expensive, in terms of the maintenance costs of colostomies and the treatment of recurrent disease, say the authors.

"These problems must be addressed if the government is to attain its aims of ensuring a high quality of cancer care for all," they conclude.

Source: BMJ-British Medical Journal

Prostatectomy improves outcome of some men with prostate cancer over watchful waiting
Men with early prostate cancer who undergo radical prostatectomy have a lower rate of death due to prostate cancer than men who are followed without treatment, known as watchful waiting, according to a randomized controlled trial published in the August 12 online issue of the Journal of the National Cancer Institute. The benefit from the surgery, with respect to prostate cancer death rates, remained constant beyond 10 years, but the overall death rates in the two groups were not statistically different. The applicability of the results to the current generation of prostate cancer patients is unclear, however, because few of the cancers treated in the trial were discovered by PSA (prostate-specific antigen) screening, a practice that is now widespread.
1 in 5 young men has had recent prostate cancer test
A new analysis finds that one in five men in their 40s has had a prostate specific antigen (PSA) test within the previous year and that young black men are more likely than young white men to have undergone the test. The study, published in the September 15, 2008 issue of Cancer, a peer-reviewed journal of the American Cancer Society, provides valuable information as experts discuss possible changes to prostate cancer screening recommendations.
PSA screening may be biased against obese men, leading to more aggressive cancers
Testing men for elevated levels of prostate-specific antigen (PSA) in the blood -- the gold standard screening test for prostate cancer -- may be biased against obese men, whose PSA levels tend to be deceptively low. And this bias may be creating more aggressive cancers in this population by delaying diagnosis, according to a new study led by investigators in the Duke Prostate Center and the Durham Veterans Affairs (VA) Medical Center.
Analysis of cancer incidence, mortality and survival combined reveals encouraging European trends
The first research to look at recent trends in European cancer incidence, mortality and survival together has shown that cancer prevention and management in Europe is moving in the right direction. However, the research reveals that variations between countries in policies for mass screening, access to health care and treatment are reflected in the different cancer rates.
Study links vitamin D to colon cancer survival
Patients diagnosed with colon cancer who had abundant vitamin D in their blood were less likely to die during a follow-up period than those who were deficient in the vitamin, according to a new study by scientists at Dana-Farber Cancer Institute.
Study underway to find an alternative cure for Crohn's disease and ulcerative colitis
Two research studies evaluating dietary changes and complementary medicine for the treatment of inflammatory bowel diseases (IBD) have been launched at Rush University Medical Center. Funded by the National Institute of Health, one study will look at the impact of mind/body medicine on patients suffering from ulcerative colitis (UC) and the other will assess how diet impacts patients with Crohn's Disease.
Researchers discover traits of aggressive form of prostate cancer
Researchers led by a team at the Michigan Center for Translational Pathology at the University of Michigan Health System have identified traits of an aggressive type of prostate cancer that occurs in about 10 percent of men who have the disease. They hope the discovery could lead, possibly within the next few years, to a simple urine test that will help to diagnose this variation of prostate cancer.
MRI useful and reliable in surgical planning of patients with rectal cancer
3T MRI can accurately stage, and help surgeons plan sphincter-sparing surgery in patients with rectal cancer, according to a recent study conducted by researchers at Qilu Hospital of Shandong University in Shandong, China.

Wide variations in appropriateness of rectal cancer surgery across England

Related stories:

News discussion: